Self‐assembled free nanocarrier prodrugs based on camptothecin and dihydroartemisinin exhibit accumulation and improved anticancer efficacy
Biotechnology and Applied Biochemistry · 2025-06 · 72 (3) · 793-804
DOI: 10.1002/bab.2698 ↗At a glance
Journal article in Biotechnology and Applied Biochemistry, published online on 2024-12-03. Written by Mohan Garg and 7 co-authors. Institution: Chitkara Centre for Research and Development, Chitkara University, Baddi, Himachal Pradesh, India. Major MEDLINE topics: Camptothecin, Artemisinins, Prodrugs, Antineoplastic Agents. Cited 3 times so far (Crossref); 52 references. Funded by: Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia.
Abstract (original language)
Small molecule targeted inhibitor therapies often have several drawbacks, including limited oral bioavailability, quick metabolism, toxic effects that limit dosage, and poor water solubility. This study aims to develop a nanodrug self‐delivery system that does not require a carrier by utilizing the self‐assembly of camptothecin (CPT) and dihydroartemisinin (DHA). CPT/DHA nanoparticles (NPs) with varying diameters can be synthesized without requiring further carrier materials or chemical modifications by changing the CPT‐to‐DHA ratio (10:1, 5:1, 2:1, 1:1). Even more crucially, CPT/DHA NPs generate an AIE impact when they self‐assemble. CPT/DHA NPs are used for cell tracking and bioimaging fluorescent probes. We chose CPT/DHA NPs (2:1) with a size of approximately 140 nm for the anticancer examinations. The A549 cells were used to assess the cytotoxicity, morphological changes by biochemical staining methods and apoptosis by flow cytometric techniques of CPT/DHA NPs. Finally, in vitro anticancer research proved that CPT/DHA NPs are biocompatible and have strong synergistic anticancer properties.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Chitkara Centre for Research and Development, Chitkara University, Baddi, Himachal Pradesh, India.
- Department of Chemistry and Biochemistry, JAIN (Deemed-to-be University), Bangalore, Karnataka, India.
- Centre of Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India.
- Department of Sciences, Vivekananda Global University, Jaipur, Rajasthan, India.
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
- Department of Pediatrics, College of Medicine and King Khalid University Hospital, King Saud University, Medical City, Riyadh, Saudi Arabia.
ORCID profiles: Mohan Garg, Roopashree Rangaswamy, Rahul Mishra, Shivangi Giri, Indumathi Thangavelu
Funding
- Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia
Cite
APA
Garg, M., Rangaswamy, R., Mishra, R., Giri, S., Chinnathambi, A., Alahmadi, T. A., Arulselvan, P., & Thangavelu, I. (2025). Self‐assembled free nanocarrier prodrugs based on camptothecin and dihydroartemisinin exhibit accumulation and improved anticancer efficacy. Biotechnology and Applied Biochemistry, 72(3), 793-804. https://doi.org/10.1002/bab.2698
Vancouver
Garg M, Rangaswamy R, Mishra R, Giri S, Chinnathambi A, Alahmadi TA, et al. Self‐assembled free nanocarrier prodrugs based on camptothecin and dihydroartemisinin exhibit accumulation and improved anticancer efficacy. Biotechnology and Applied Biochemistry. 2025;72(3):793-804. doi:10.1002/bab.2698
BibTeX
@article{Garg2025,
author = {Garg, Mohan and Rangaswamy, Roopashree and Mishra, Rahul and Giri, Shivangi and Chinnathambi, Arunachalam and Alahmadi, Tahani Awad and Arulselvan, Palanisamy and Thangavelu, Indumathi},
title = {Self‐assembled free nanocarrier prodrugs based on camptothecin and dihydroartemisinin exhibit accumulation and improved anticancer efficacy},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
volume = {72},
number = {3},
pages = {793--804},
doi = {10.1002/bab.2698}
}
EUVIMED